Intralytix Revenue and Competitors

Columbia, MD USA

Location

$17.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Intralytix's estimated annual revenue is currently $2.9M per year.(i)
  • Intralytix's estimated revenue per employee is $77,500
  • Intralytix's total funding is $17.5M.

Employee Data

  • Intralytix has 38 Employees.(i)
  • Intralytix grew their employee count by -31% last year.

Intralytix's People

NameTitleEmail/Phone
1
VP Clinical DevelopmentReveal Email/Phone
2
VP Production and LogisticsReveal Email/Phone
3
VP Laboratory OperationsReveal Email/Phone
4
VP Clinical DevelopmentReveal Email/Phone
5
Director ManufacturingReveal Email/Phone
6
Director Quality AssuranceReveal Email/Phone
7
Director Food SafetyReveal Email/Phone
8
Facilities Operations ManagerReveal Email/Phone
9
Shipping ManagerReveal Email/Phone
10
President & CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Intralytix?

lntralytix was founded in 1998 to address growing problems in the control and treatment of disease-causing bacteria. These problems are presently compounded by public and governmental reluctance to employ new and potentially hazardous chemical agents or solutions born of recombinant technology. Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy

keywords:N/A

$17.5M

Total Funding

38

Number of Employees

$2.9M

Revenue (est)

-31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Intralytix News

2022-04-17 - Bacteriophage Therapy Market 2022 to See Major Growth by ...

Intralytix Inc. Pherecydes Pharma; Eliava Bio Preparations LTD; NEXTBIOTICS; LOCUS BIOSCIENCES INC. Fixed-Phage Limited; Phage International Inc. iNtODEWORLD...

2022-04-13 - Phage Therapy Market Size [2022-2028] | is Projected to Reach USD 100.8 Million, with 17.6% CAGR | Growth Rate, Share, New Developments, Market Dynamics, Key Players, Revenue, and Expansion Plans, Research | Market Reports World

The major key players are - NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M38-17%N/A
#2
N/A38-3%N/A
#3
N/A3881%N/A
#4
$6.4M3852%N/A
#5
$4.4M380%N/A